Revenue
327.80B DKK
Gross Margin
+81.8%
Operating Margin
+45.3%
Net Margin
+37.2%
Income statement waterfall for Novo Nordisk (NVO) — TTM through Q1 2026
Net income: 121.96B DKK
Margin breakdown for Novo Nordisk (NVO) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | 327.80B DKK | 327.80B DKK |
| Cost of Revenue | −59.50B DKK | 268.30B DKK |
| Gross Profit | 268.30B DKK | 268.30B DKK |
| Operating Expenses | −119.82B DKK | 148.49B DKK |
| Operating Income | 148.49B DKK | 148.49B DKK |
| Other Income / Expense | 7.19B DKK | 155.68B DKK |
| Pre-tax Income | 155.68B DKK | 155.68B DKK |
| Income Tax | −33.72B DKK | 121.96B DKK |
| Net Income | 121.96B DKK | 121.96B DKK |
- Revenue327.80B DKK
- Cost of Revenue−59.50B DKK
- Gross Profit268.30B DKK
- Operating Expenses−119.82B DKK
- Operating Income148.49B DKK
- Other Income / Expense7.19B DKK
- Pre-tax Income155.68B DKK
- Income Tax−33.72B DKK
- Net Income121.96B DKK
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement